FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1537228032> ?p ?o ?g. }

• W1537228032 endingPage "2502" @default.
• W1537228032 startingPage "2494" @default.
• W1537228032 abstract "Rates of nonadherence to aromatase inhibitors (AIs) among Medicare beneficiaries with hormone receptor-positive early breast cancer are high. Out-of-pocket drug costs appear to be an important contributor to this and may be addressed by eliminating copayments and other forms of patient cost sharing. The authors estimated the incremental cost-effectiveness of providing Medicare beneficiaries with full prescription coverage for AIs compared with usual prescription coverage under the Medicare Part D program.A Markov state-transition model was developed to simulate AI use and disease progression in a hypothetical cohort of postmenopausal Medicare beneficiaries with hormone receptor-positive early breast cancer. The analysis was conducted from the societal perspective and considered a lifetime horizon. The main outcome was an incremental cost-effectiveness ratio, which was measured as the cost per quality-adjusted life-year (QALY) gained.For patients receiving usual prescription coverage, average quality-adjusted survival was 11.35 QALYs, and lifetime costs were $83,002. For patients receiving full prescription coverage, average quality-adjusted survival was 11.38 QALYs, and lifetime costs were $82,728. Compared with usual prescription coverage, full prescription coverage would result in greater quality-adjusted survival (0.03 QALYs) and less resource use ($275) per beneficiary. From the perspective of Medicare, full prescription coverage was cost-effective (incremental cost-effectiveness ratio, $15,128 per QALY gained) but not cost saving.Providing full prescription coverage for AIs to Medicare beneficiaries with hormone receptor-positive early breast cancer would both improve health outcomes and save money from the societal perspective." @default.
• W1537228032 created "2016-06-24" @default.
• W1537228032 creator A5001498977 @default.
• W1537228032 creator A5063707394 @default.
• W1537228032 creator A5066655122 @default.
• W1537228032 creator A5086581232 @default.
• W1537228032 creator A5091282674 @default.
• W1537228032 date "2013-04-23" @default.
• W1537228032 modified "2023-10-07" @default.
• W1537228032 title "Cost-effectiveness of full coverage of aromatase inhibitors for Medicare beneficiaries with early breast cancer" @default.
• W1537228032 cites W1881540319 @default.
• W1537228032 cites W1901711706 @default.
• W1537228032 cites W1904695471 @default.
• W1537228032 cites W1972362505 @default.
• W1537228032 cites W1979160865 @default.
• W1537228032 cites W1984959392 @default.
• W1537228032 cites W1987753117 @default.
• W1537228032 cites W1988434973 @default.
• W1537228032 cites W1996337195 @default.
• W1537228032 cites W2010030230 @default.
• W1537228032 cites W2012942082 @default.
• W1537228032 cites W2015473392 @default.
• W1537228032 cites W2020462643 @default.
• W1537228032 cites W2040739094 @default.
• W1537228032 cites W2042707001 @default.
• W1537228032 cites W2047684438 @default.
• W1537228032 cites W2051836194 @default.
• W1537228032 cites W2053229432 @default.
• W1537228032 cites W2058621175 @default.
• W1537228032 cites W2071003201 @default.
• W1537228032 cites W2072985818 @default.
• W1537228032 cites W2101944829 @default.
• W1537228032 cites W2106286200 @default.
• W1537228032 cites W2112780046 @default.
• W1537228032 cites W2112821676 @default.
• W1537228032 cites W2118728607 @default.
• W1537228032 cites W2118781681 @default.
• W1537228032 cites W2122833169 @default.
• W1537228032 cites W2129906534 @default.
• W1537228032 cites W2134839096 @default.
• W1537228032 cites W2149615486 @default.
• W1537228032 cites W2150962478 @default.
• W1537228032 cites W2154734961 @default.
• W1537228032 cites W2154835844 @default.
• W1537228032 cites W2159787866 @default.
• W1537228032 cites W2160831710 @default.
• W1537228032 cites W2169902698 @default.
• W1537228032 cites W2170915815 @default.
• W1537228032 cites W2917423152 @default.
• W1537228032 doi "https://doi.org/10.1002/cncr.28084" @default.
• W1537228032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23775433" @default.
• W1537228032 hasPublicationYear "2013" @default.
• W1537228032 type Work @default.
• W1537228032 sameAs 1537228032 @default.
• W1537228032 citedByCount "15" @default.
• W1537228032 countsByYear W15372280322013 @default.
• W1537228032 countsByYear W15372280322014 @default.
• W1537228032 countsByYear W15372280322015 @default.
• W1537228032 countsByYear W15372280322016 @default.
• W1537228032 countsByYear W15372280322017 @default.
• W1537228032 countsByYear W15372280322018 @default.
• W1537228032 countsByYear W15372280322019 @default.
• W1537228032 countsByYear W15372280322021 @default.
• W1537228032 countsByYear W15372280322022 @default.
• W1537228032 crossrefType "journal-article" @default.
• W1537228032 hasAuthorship W1537228032A5001498977 @default.
• W1537228032 hasAuthorship W1537228032A5063707394 @default.
• W1537228032 hasAuthorship W1537228032A5066655122 @default.
• W1537228032 hasAuthorship W1537228032A5086581232 @default.
• W1537228032 hasAuthorship W1537228032A5091282674 @default.
• W1537228032 hasBestOaLocation W15372280321 @default.
• W1537228032 hasConcept C10138342 @default.
• W1537228032 hasConcept C112930515 @default.
• W1537228032 hasConcept C121608353 @default.
• W1537228032 hasConcept C126322002 @default.
• W1537228032 hasConcept C159110408 @default.
• W1537228032 hasConcept C162324750 @default.
• W1537228032 hasConcept C175444787 @default.
• W1537228032 hasConcept C2426938 @default.
• W1537228032 hasConcept C26869875 @default.
• W1537228032 hasConcept C2776291444 @default.
• W1537228032 hasConcept C2776680279 @default.
• W1537228032 hasConcept C2778858636 @default.
• W1537228032 hasConcept C3019080777 @default.
• W1537228032 hasConcept C530470458 @default.
• W1537228032 hasConcept C64332521 @default.
• W1537228032 hasConcept C66887028 @default.
• W1537228032 hasConcept C71924100 @default.
• W1537228032 hasConcept C72563966 @default.
• W1537228032 hasConcept C98274493 @default.
• W1537228032 hasConceptScore W1537228032C10138342 @default.
• W1537228032 hasConceptScore W1537228032C112930515 @default.
• W1537228032 hasConceptScore W1537228032C121608353 @default.
• W1537228032 hasConceptScore W1537228032C126322002 @default.
• W1537228032 hasConceptScore W1537228032C159110408 @default.
• W1537228032 hasConceptScore W1537228032C162324750 @default.
• W1537228032 hasConceptScore W1537228032C175444787 @default.
• W1537228032 hasConceptScore W1537228032C2426938 @default.

• next